Agurklių aliejus (Lithuanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Agurklių aliejus" in Lithuanian language version.

refsWebsite

Global rank Lithuanian rank

4^th place

12^th place

2^nd place

10^th place

6^th place

14^th place

low place

9,622^nd place

archive.org

Henz, BM; Jablonska, S; Van De Kerkhof, PC; Stingl, G; Blaszczyk, M; Vandervalk, PG; Veenhuizen, R; Muggli, R; Raederstorff, D (1999). „Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema“. The British journal of dermatology. 140 (4): 685–8. PMID 10233322.
Wretensjoe, Inger; Karlberg, Bo. (2003). „Pyrrolizidine alkaloid content in crude and processed borage oil from different processing stages“. Journal of the American Oil Chemists' Society. 80 (10): 963–970. doi:10.1007/s11746-003-0804-z.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)

Takwale, A; Tan, E; Agarwal, S; Barclay, G; Ahmed, I; Hotchkiss, K; Thompson, JR; Chapman, T; Berth-Jones, J (2003). „Efficacy and tolerability of borage oil in adults and children with atopic eczema: Randomised, double blind, placebo controlled, parallel group trial“. BMJ (Clinical research ed.). 327 (7428): 1385. doi:10.1136/bmj.327.7428.1385. PMC 292992. PMID 14670885.
Dodson, Craig D.; Stermitz, Frank R. (1986). „Pyrrolizidine alkaloids from borage (Borago officinalis) seeds and flowers“. Journal of Natural Products. 49 (4): 727–728. doi:10.1021/np50046a045.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)
Wretensjoe, Inger; Karlberg, Bo. (2003). „Pyrrolizidine alkaloid content in crude and processed borage oil from different processing stages“. Journal of the American Oil Chemists' Society. 80 (10): 963–970. doi:10.1007/s11746-003-0804-z.{{cite journal}}: CS1 priežiūra: multiple names: authors list (link)
Bamford, JT; Ray, S; Musekiwa, A; van Gool, C; Humphreys, R; Ernst, E (Apr 30, 2013). „Oral evening primrose oil and borage oil for eczema“. The Cochrane Database of Systematic Reviews. 4 (4): CD004416. doi:10.1002/14651858.CD004416.pub2. PMC 8105655. PMID 23633319.

Henz, BM; Jablonska, S; Van De Kerkhof, PC; Stingl, G; Blaszczyk, M; Vandervalk, PG; Veenhuizen, R; Muggli, R; Raederstorff, D (1999). „Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema“. The British journal of dermatology. 140 (4): 685–8. PMID 10233322.
Takwale, A; Tan, E; Agarwal, S; Barclay, G; Ahmed, I; Hotchkiss, K; Thompson, JR; Chapman, T; Berth-Jones, J (2003). „Efficacy and tolerability of borage oil in adults and children with atopic eczema: Randomised, double blind, placebo controlled, parallel group trial“. BMJ (Clinical research ed.). 327 (7428): 1385. doi:10.1136/bmj.327.7428.1385. PMC 292992. PMID 14670885.
Kast, RE (2001). „Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha“. International immunopharmacology. 1 (12): 2197–9. PMID 11710548.
Bamford, JT; Ray, S; Musekiwa, A; van Gool, C; Humphreys, R; Ernst, E (Apr 30, 2013). „Oral evening primrose oil and borage oil for eczema“. The Cochrane Database of Systematic Reviews. 4 (4): CD004416. doi:10.1002/14651858.CD004416.pub2. PMC 8105655. PMID 23633319.

Takwale, A; Tan, E; Agarwal, S; Barclay, G; Ahmed, I; Hotchkiss, K; Thompson, JR; Chapman, T; Berth-Jones, J (2003). „Efficacy and tolerability of borage oil in adults and children with atopic eczema: Randomised, double blind, placebo controlled, parallel group trial“. BMJ (Clinical research ed.). 327 (7428): 1385. doi:10.1136/bmj.327.7428.1385. PMC 292992. PMID 14670885.
Bamford, JT; Ray, S; Musekiwa, A; van Gool, C; Humphreys, R; Ernst, E (Apr 30, 2013). „Oral evening primrose oil and borage oil for eczema“. The Cochrane Database of Systematic Reviews. 4 (4): CD004416. doi:10.1002/14651858.CD004416.pub2. PMC 8105655. PMID 23633319.